Accéder au contenu
Merck
HomeWebinarsNovel Perfusion Filter for N-1 Application

Novel Perfusion Filter for N-1 Application



WEBINAR

Process intensification has become a strategic focus aimed at efficiently increasing productivity. A key example of this in upstream is utilizing perfusion within the seed train, yielding a reduction in process time and/or increase in manufacturing capacity without increasing volume capacity. With recent advances in cell retention technologies, coupled with advancements in cell line and media development, perfusion processes are becoming a more viable solution. We will present a case study utilizing our novel perfusion filter and controller along with a newly developed expansion medium, demonstrating an ideal solution to intensify upstream processing.

In this webinar, you will learn about:

  • Considerations for a scalable cell retention device for perfusion applications
  • A case study demonstrating capabilities of novel perfusion filter and controller for intensified upstream processing

Speakers

Alison Dupont

Alison Dupont

Merck

Senior Applications Engineer, Single-Use and Integrated Systems

Alison Dupont is a senior applications engineer within the single-use and integrated systems group. She holds an M.S. in chemical engineering. Her current role is to be the “customer ambassador” on active product development projects within the single-use and integrated system product pipeline. Alison has more than 14 years of experience in MAb processing in both upstream and downstream, with a focus on intensified processing.

Allyson Fournier

Allyson Fournier

Merck

Application Engineer, Single-Use and Integrated Systems R&D

Allyson Fournier has been highly involved with the development of a line of novel cell retention filters and systems to be used on a perfusion bioreactor. She supports the single-use and integrated systems R&D team to provide application work for the launch of new products. Allyson brings a background in chemical engineering and biotechnology.

Webinar Information

Pharma and biopharma manufacturing

  • Cell Line Development
  • Durée:46min

  • Langue:English

  • Session 1:présenté(e) January 23, 2020

    Watch Now


Connectez-vous pour continuer

Pour continuer à lire, veuillez vous connecter à votre compte ou en créer un.

Vous n'avez pas de compte ?